0.5 ML eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection
- RxCUI
- 2698771
- RxNorm name
- 0.5 ML eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection
- Display name
- 0.5 ML eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection
- Full name
- 0.5 ML eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125722 | KEBILIDI | eladocagene exuparvovec-tneq | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KEBILIDI | ELADOCAGENE EXUPARVOVEC-TNEQ | PTC Therapeutics, Inc. | 9d6a6401-c6b5-4f29-af11-67707d249482 | 2026-06-11 | Warnings, Adverse reactions | 2698771 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9d6a6401-c6b5-4f29-af11-67707d249482 | 0.5 ML eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection | SCD | 3 | These highlights do not include all the information needed to use KEBILIDI safely and effectively. See full prescribing information for KEBILIDI. KEBILIDI (eladocagene exuparvovec-tneq) suspension, for intraputaminal infusion Initial U.S. Approval: 2024 | 20260113 |
| 9d6a6401-c6b5-4f29-af11-67707d249482 | eladocagene exuparvovec-tneq 560,000,000,000 VECTOR-GENOMES per 0.5 ML Injection | SY | 3 | These highlights do not include all the information needed to use KEBILIDI safely and effectively. See full prescribing information for KEBILIDI. KEBILIDI (eladocagene exuparvovec-tneq) suspension, for intraputaminal infusion Initial U.S. Approval: 2024 | 20260113 |
| 9d6a6401-c6b5-4f29-af11-67707d249482 | eladocagene exuparvovec-tneq 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | PSN | 3 | These highlights do not include all the information needed to use KEBILIDI safely and effectively. See full prescribing information for KEBILIDI. KEBILIDI (eladocagene exuparvovec-tneq) suspension, for intraputaminal infusion Initial U.S. Approval: 2024 | 20260113 |